NaturalX Unveils €100M Fund to Boost Europe's Consumer Health Startups

February 17, 2025
NaturalX Unveils €100M Fund to Boost Europe's Consumer Health Startups
  • NaturalX Health Ventures, the venture capital arm of Schwabe Group, has launched a €100 million fund aimed at supporting early-stage consumer health startups across Europe.

  • This investment strategy leverages Schwabe Group's extensive pharmaceutical expertise alongside digital health innovations, with the goal of mirroring the successful U.S. market model in Europe.

  • Marvin Amberg, the founder of NaturalX, believes the European consumer health market is on the brink of significant growth, akin to trends observed in the U.S., where consumer-focused healthcare companies have thrived.

  • The consumer health market is evolving, driven by a growing interest among consumers in preventive health and science-backed products and services.

  • The fund will concentrate on proactive health solutions, particularly in areas such as sleep, gut health, prevention, longevity, and mental health, addressing the needs of underserved consumers.

  • NaturalX has already made investments in several startups, including mybacs, Flow Neuroscience, Kyan Health, and Meela, during its initial 18-month ramp-up phase.

  • The fund will primarily target Series A investments, with initial funding typically ranging from €3 million to €5 million, and potential follow-on investments of up to €10 million per company.

  • Amberg expressed enthusiasm for the fund's launch, noting a rising consumer focus on health management influenced by the COVID-19 pandemic and increasing health literacy.

  • Despite the success of American companies in the consumer health sector, European startups often struggle to secure necessary investments, a gap that NaturalX aims to fill.

  • NaturalX defines consumer health as the intersection of wellness and medicine, emphasizing the importance of science-backed products and services that prioritize consumer needs.

  • The entire €100 million fund has been financed by Schwabe, a well-established pharmaceutical conglomerate with a 150-year history.

  • The fund is actively expanding its investment team and seeks partnerships with European entrepreneurs who share its vision for reshaping consumer health.

Summary based on 6 sources


Get a daily email with more Startups stories

Sources




New €100 million fund aims to drive consumer health innovation in Europe

Longevity.Technology - Latest News, Opinions, Analysis and Research • Feb 18, 2025

New €100 million fund aims to drive consumer health innovation in Europe

More Stories